Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:August 27, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:August 27, 2018Completed
Condition(s):HIV InfectionLast Updated:June 26, 2017Completed
Condition(s):HIV InfectionsLast Updated:August 16, 2010Terminated
Condition(s):HIV-1Last Updated:October 26, 2010Terminated
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:February 22, 2024Completed
Condition(s):HIV InfectionsLast Updated:November 20, 2012Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:February 10, 2014Completed
Condition(s):HIVLast Updated:April 5, 2021Approved for marketing
Condition(s):HealthyLast Updated:March 27, 2024Active, not recruiting
Condition(s):HealthyLast Updated:April 7, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.